4.7 Article

The Poorly Explored Impact of Uncontrolled Asthma

Journal

CHEST
Volume 143, Issue 2, Pages 511-523

Publisher

ELSEVIER
DOI: 10.1378/chest.12-0412

Keywords

-

Funding

  1. Chiesi Farmaceutici SpA
  2. Amgen Inc
  3. Asmacure Ltee
  4. AstraZeneca
  5. Genentech Inc.
  6. GlaxoSmithKline plc
  7. Takeda Pharmaceuticals International GmbH
  8. Aerocrine
  9. Genentech Inc
  10. Merck Co
  11. National Institute of Allergy and Infectious Diseases, National Institutes of Health
  12. National Heart, Lung, and Blood Institute, National Institutes of Health

Ask authors/readers for more resources

The goal of asthma management is to achieve disease control; however, despite the availability of effective and safe medications, for many patients asthma remains uncontrolled. One reason for this is the fear of long-term side effects from the regular use of inhaled corticosteroids (ICSs). Adverse effects of poorly controlled asthma (for example, obesity, pneumonia, and risks to the fetus) can be perceived as side effects of ICSs. Poorly controlled asthma adversely affects children's cardiovascular fitness, while children with well-controlled asthma perform at the same level as their peers. Children with uncontrolled asthma also have a higher frequency of obesity than children with controlled asthma. Stress can affect asthma control, and children with poorly controlled asthma are more likely to have learning disabilities compared with those with good control. In adults, focused attention and concentration are negatively affected in patients with untreated asthma, and patients with asthma are at greater risk for depression. Also, poorly controlled asthma increases the risks of severe asthma exacerbations following upper respiratory and pneumococcal pulmonary infections. ICSs used to improve asthma control have been demonstrated to improve all of these outcomes. Lastly, the risks of uncontrolled asthma during pregnancy are substantially greater than the risks of recommended asthma medications. Treatments to maintain asthma control are the best approach to optimize maternal and fetal health in the pregnancies of women with asthma. The maintenance of asthma control has significant advantages to patients and greatly outweighs the potential risks of treatment side effects. CHEST 2013; 143(2):511-523

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available